ESC TV Today – Your Cardiovascular News Season 4 - Ep1: What´s new in TAVI? - Digital solutions in arrhythmias
20 snips
Jan 22, 2026 Join interventional cardiologist Davide Capodanno, who reviews the latest TAVI evidence, including durability and risks for younger patients. Cardiac electrophysiologist Fleur Tjong discusses the role of wearables and AI in ECGs, highlighting how these tools can refine device therapy decisions. Cardiology commentator JP Carpenter provides summaries of recent cardiovascular studies, addressing the implications for statins and exercise. The panel also explores intriguing links between gratitude and heart health.
AI Snips
Chapters
Transcript
Episode notes
Intervene In Selected Asymptomatic Patients
- Consider intervention in asymptomatic severe aortic stenosis when LVEF <50% or high-risk features are present.
- Use team assessment to choose between surgery or TAVI for these patients.
Bicuspid Anatomy Still Favors Surgery
- Bicuspid valves were largely excluded from landmark TAVI trials, so surgery remains first-line.
- Some bicuspid morphologies with limited calcification may still do reasonably well with TAVI.
Higher Conduction Risk With TAVI
- Conduction abnormalities and pacemaker need are more common after TAVI than surgery, higher with self-expanding valves.
- Reported pacemaker rates were roughly 17% with balloon-expandable and 27% with self-expanding valves in trials cited.